KERA Recombinant antibody

KERA Uni-rAbTM Recombinant Antibody for FC (Intra), ELISA
Cat No. 83272-1-RR

产品说明书

CloneNo. 230399B11

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC (Intra), ELISA

Keratocan, SLRR2B, KTN, CNA2, 230399B11

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
规格: 

-/ -


经过测试的应用

Positive FC (Intra) detected inU251

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.20 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

83272-1-RR targets KERA in FC (Intra), ELISA applications and shows reactivity with human samples.

经测试应用 FC (Intra), ELISA Application Description
经测试反应性 human
免疫原 KERA fusion protein Ag34171 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 keratocan
别名 Keratocan, SLRR2B, KTN, CNA2, 230399B11
计算分子量 352 aa, 41 kDa
GenBank蛋白编号BC032667
基因名称 KERA
Gene ID (NCBI) 11081
RRIDAB_3670944
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purfication
UNIPROT IDO60938
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

Keratocan and Lumican are the predominant class II SLRPs(Small leucine-rich proteoglycans) in the corneal stroma. While not totally corneal-specific together these SLRPs are excellent biomarkers for the tissue. Mutant mice deficient for keratocan expression have transparent but thin corneal stromas with a mild increase in collagen fibril diameter with no further abnormalities.In humans, mutations in the keratocan gene are associated with a flattened cornea in a rare condition known as cornea plana. The relative specificity of keratocan to corneal keratocytes has been useful for tissue-specific targeting for genetic manipulation of the corneal stroma.(PMID: 32663498)

实验方案

Product Specific Protocols
FC protocol for KERA antibody 83272-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...